Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities

Ann Neurol. 2020 Jul;88(1):199-200. doi: 10.1002/ana.25764. Epub 2020 May 19.

Authors

Alberto Vogrig^{1

2

3}, Sergio Muñiz-Castrillo^{1

2

3}, Jérôme Honnorat^{1

2

3}

Affiliations

¹ National Reference Center for Paraneoplastic Neurological Syndromes, Lyon Civil Hospices, Neurological Hospital, Lyon, France.
² Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France.
³ University Claude Bernard Lyon 1, University of Lyon, Lyon, France.

PMID: 32386101
DOI: 10.1002/ana.25764

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies*
Humans
Immunologic Factors
Paraneoplastic Syndromes, Nervous System*

Substances

Antibodies
Immunologic Factors